Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.96 |
| ▸ | NAAA | Q02083 | 1/20 | 0.55 |
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.51 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.51 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.51 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | RAD52 | P43351 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3822217 | 0.98 | HTR2C (1.00) | HTR2CNAAADGKAPRSS1PRSS2 | |
| SCHEMBL3829077 | 0.98 | HTR2C (1.00) | HTR2CNAAADGKAPRSS1PRSS2 | |
| Hexaminolevulinate SCHEMBL1070663 | 0.98 | HTR2C (1.00) | HTR2CNAAADGKAPRSS1PRSS2 | |
| SCHEMBL3824698 | 0.98 | HTR2C (1.00) | HTR2CNAAADGKAPRSS1PRSS2 | |
| SCHEMBL3819717 | 0.98 | HTR2C (1.00) | HTR2CNAAADGKAPRSS1PRSS2 | |
| SCHEMBL3822297 | 0.98 | HTR2C (1.00) | HTR2CNAAADGKAPRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL1613827 | 0.96 | HTR2C (0.97) | HTR2CNAAADGKAPRSS1PRSS2 | |
| Hexaminolevulinate SCHEMBL937621 | 0.96 | HTR2C (0.97) | HTR2CNAAADGKAPRSS1PRSS2 | |
| Hydrochloric Acid SCHEMBL1613756 | 0.96 | HTR2C (0.97) | HTR2CNAAADGKAPRSS1PRSS2 | |
| SCHEMBL987461 | 0.94 | HTR2C (0.86) | HTR2CNAAADGKAPRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2272538-B1 | METHOD OF DETECTING BLADDER CANCER | SBI PHARMACEUTICALS CO LTD (JP) | 2020-09-02 | — | — | EP | claimed |
| CN-104524576-A | Use of aminolevulinic acid and derivatives thereof | PHOTOCURE ASA | 2015-04-22 | — | — | CN | claimed |
| CN-101896203-A | Use of solid forms of 5-aminolevulinic acid and derivatives in photodynamic therapy and diagnosis | PHOTOCURE ASA | 2010-11-24 | — | — | CN | claimed |
| CN-101631541-A | Application of aminolevulinic acid and derivatives thereof | PHOTOCURE ASA | 2010-01-20 | — | — | CN | claimed |
| EP-1467706-B1 | DERMAL APPLICATION SYSTEM FOR AMINOLEVULINIC ACID-DERIVATIVES | PHOTONAMIC GMBH & CO KG (DE) | 2007-03-14 | — | — | EP | claimed |
| US-20060018956-A1 | Dermal application system for aminolevulinic acid-derivatives | PHOTONAMIC GMBH & CO. KG (DE) | 2006-01-26 | — | — | US | claimed |
| EP-4548917-A1 | NON-AQUEOUS PREPARATION WITH EXCELLENT STABILITY | Kiyan Pharma Co., Ltd. (JP) | 2025-05-07 | — | — | EP | disclosed |
| CN-119874643-A | Paclitaxel prodrug, and preparation method and application thereof | 中国药科大学 | 2025-04-25 | — | — | CN | disclosed |
| CN-119365191-A | Nonaqueous formulations with excellent stability | 基扬制药有限公司 | 2025-01-24 | — | — | CN | disclosed |
| US-20240299588-A1 | NERVE LABEL | UCL Business Ltd, University College London (GB) | 2024-09-12 | — | — | US | disclosed |
| EP-4370166-A1 | NERVE LABEL | UCL Business Ltd (GB) | 2024-05-22 | — | — | EP | disclosed |
| WO-2024005178-A1 | NON-AQUEOUS PREPARATION WITH EXCELLENT STABILITY | ネオファーマジャパン株式会社 | 2024-01-04 | — | — | WO | disclosed |
| WO-2023106413-A1 | STABILIZED 5-AMINOLEVULINIC ACID COMPOSITION | ネオファーマジャパン株式会社 | 2023-06-15 | — | — | WO | disclosed |
| US-20090176881-A1 | Unsaturated Alkyl Esters of 5-Aminolevulinic Acid, their Preparation and their Use | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2009-07-09 | — | — | US | disclosed |
| EP-2055188-A1 | POLYPHENOL-CONTENT-INCREASING AGENT FOR PLANT | COSMO OIL CO., LTD. (JP) | 2009-05-06 | — | — | EP | disclosed |
| US-7135162-B2 | Agent for diagnosing and treating malignant tumors | COSMO RESEARCH INSTITUTE (JP) | 2006-11-14 | — | — | US | disclosed |
| US-20060018956-A1 | Dermal application system for aminolevulinic acid-derivatives | PHOTONAMIC GMBH & CO. KG (DE) | 2006-01-26 | — | — | US | disclosed |
| US-6905671-B1 | Diagnostic agents and remedies for malignant tumors | COSMO RESEARCH INSTITUTE (JP) | 2005-06-14 | — | — | US | disclosed |
| US-20030065029-A1 | Agent for diagnosing and treating malignant tumors | COSMO RESEARCH INSTITUTE, COSMO OIL CO., LTD. | 2003-04-03 | — | — | US | disclosed |
| EP-0995448-A1 | DIAGNOSTIC AGENTS AND REMEDIES FOR MALIGNANT TUMORS | Cosmo Research Institute (JP) | 2000-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240299588-A1 | NERVE LABEL | GAP43, NT5M, NT5E | HTR2C 2314/4885NAAA 378/4885DGKA 4456/4885 |
| US-20090176881-A1 | Unsaturated Alkyl Esters of 5-Aminolevulinic Acid, their Preparation and their Use | ALAD, ALOX5, SLC7A1 | HTR2C 1116/4885NAAA 2033/4885DGKA 2663/4885 |
| US-20030065029-A1 | Agent for diagnosing and treating malignant tumors | ALAD, VHL, AADAT | HTR2C 2838/4885NAAA 180/4885DGKA 4509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.